ArticleScientific reports2026
Comprehensive guide for optimizing octopus immune cell preparation to enhance single cell RNA sequencing success.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The common octopus, Octopus vulgaris, is renowned for its advanced nervous system and complex behavior, yet its immune system remains poorly understood despite its relevance for health and pathogen resistance. Understanding octopus immunity is key to sustainable aquaculture and animal welfare. Single-cell RNA sequencing (scRNA-seq) provides high-resolution insights into immune cell diversity but requires viable single-cell suspensions, which are challenging in octopus hemocytes due to aggregation, high salinity, and chemical constraints. This study presents an optimized protocol for isolating circulating hemocytes and white body-resident hemocytes (WBH) from O. vulgaris. Hemocytes resuspended in Marine Antiaggregant Solution (MAS) maintained > 90% viability and structural integrity for at least 2 h post‑extraction, while WBH were dissociated using combined mechanical and enzymatic methods. Cell counting comparisons revealed poor correlation between LUNA-FL and flow cytometry, whereas Neubauer chamber counts aligned closely with cytometry data. Furthermore, a reduced-EDTA MAS medium (MAS low) proved compatible with 10 × Genomics chemistry, enabling successful GEM generation, reverse transcription, and cDNA library construction. Shallow sequencing confirmed recovery of high-quality transcriptomes and distinct hemocyte populations, demonstrating the feasibility of scRNA-seq in this non-model marine species. These findings provide the first methodological framework for applying scRNA-seq to octopus immune cells, enabling detailed analysis of hemocyte diversity and function. This pipeline establishes the foundation for investigating immune responses and adaptation and offers a valuable tool for extending single-cell applications to other marine invertebrates, enhancing immunity understanding of cephalopod immunity, and supporting animal welfare and sustainable aquaculture practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.